199 related articles for article (PubMed ID: 22731636)
41. MEK1 inhibits cardiac PPARĪ± activity by direct interaction and prevents its nuclear localization.
el Azzouzi H; Leptidis S; Bourajjaj M; van Bilsen M; da Costa Martins PA; De Windt LJ
PLoS One; 2012; 7(6):e36799. PubMed ID: 22723831
[TBL] [Abstract][Full Text] [Related]
42. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways.
Luo Y; Liang F; Zhang ZY
Biochemistry; 2009 Mar; 48(8):1838-46. PubMed ID: 19199380
[TBL] [Abstract][Full Text] [Related]
43. KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer.
Yeh JJ; Routh ED; Rubinas T; Peacock J; Martin TD; Shen XJ; Sandler RS; Kim HJ; Keku TO; Der CJ
Mol Cancer Ther; 2009 Apr; 8(4):834-43. PubMed ID: 19372556
[TBL] [Abstract][Full Text] [Related]
44. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
45. Periodic Mechanical Stress Induces Extracellular Matrix Expression and Migration of Rat Nucleus Pulposus Cells Through Src-GIT1-ERK1/2 Signaling Pathway.
Gao G; Li H; Huang Y; Yin J; Jiang Y; Xu N; Zhou D; Nong L; Ren K
Cell Physiol Biochem; 2018; 50(4):1510-1521. PubMed ID: 30359987
[TBL] [Abstract][Full Text] [Related]
46. A novel signaling pathway associated with Lyn, PI 3-kinase and Akt supports the proliferation of myeloma cells.
Iqbal MS; Tsuyama N; Obata M; Ishikawa H
Biochem Biophys Res Commun; 2010 Feb; 392(3):415-20. PubMed ID: 20079716
[TBL] [Abstract][Full Text] [Related]
47. beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells.
Broca C; Quoyer J; Costes S; Linck N; Varrault A; Deffayet PM; Bockaert J; Dalle S; Bertrand G
J Biol Chem; 2009 Feb; 284(7):4332-42. PubMed ID: 19074139
[TBL] [Abstract][Full Text] [Related]
48. Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells.
Smith ER; Cai KQ; Smedberg JL; Ribeiro MM; Rula ME; Slater C; Godwin AK; Xu XX
PLoS One; 2010 Feb; 5(2):e9295. PubMed ID: 20174585
[TBL] [Abstract][Full Text] [Related]
49. Down-regulation of c-Cbl by morphine accounts for persistent ERK1/2 signaling in delta-opioid receptor-expressing HEK293 cells.
Eisinger DA; Ammer H
J Biol Chem; 2009 Dec; 284(50):34819-28. PubMed ID: 19828455
[TBL] [Abstract][Full Text] [Related]
50. ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1.
Godeny MD; Sayeski PP
Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1308-17. PubMed ID: 16723511
[TBL] [Abstract][Full Text] [Related]
51. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer.
Wang J; Yu S; Cui L; Wang W; Li J; Wang K; Lao X
BMC Cancer; 2015 Mar; 15():90. PubMed ID: 25884313
[TBL] [Abstract][Full Text] [Related]
52. Src family kinase and adenosine differentially regulate multiple MAP kinases in ischemic myocardium: modulation of MAP kinases activation by ischemic preconditioning.
Takeishi Y; Huang Q; Wang T; Glassman M; Yoshizumi M; Baines CP; Lee JD; Kawakatsu H; Che W; Lerner-Marmarosh N; Zhang C; Yan C; Ohta S; Walsh RA; Berk BC; Abe J
J Mol Cell Cardiol; 2001 Nov; 33(11):1989-2005. PubMed ID: 11708843
[TBL] [Abstract][Full Text] [Related]
53. Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells.
Yoshizaki A; Nakayama T; Yamazumi K; Yakata Y; Taba M; Sekine I
Int J Oncol; 2006 Oct; 29(4):869-76. PubMed ID: 16964382
[TBL] [Abstract][Full Text] [Related]
54. Low expression of CD24 is associated with poor survival in colorectal cancer.
Nersisyan S; Ahlers AK; Lange T; Wicklein D; Galatenko A; Bohnenberger H; Elakad O; Conradi LC; Genduso S; Maar H; Schiecke A; Maltseva D; Raygorodskaya M; Makarova J; Schumacher U; Tonevitsky A
Biochimie; 2022 Jan; 192():91-101. PubMed ID: 34637894
[TBL] [Abstract][Full Text] [Related]
55. ERK1/2 pathway is involved in the inhibitory effect of crocetin on angiotensin II-induced vascular smooth muscle cell proliferation.
Zhou CH; Qian ZY; Zheng SG; Xiang M
Eur J Pharmacol; 2006 Mar; 535(1-3):61-8. PubMed ID: 16580346
[TBL] [Abstract][Full Text] [Related]
56. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
57. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2.
Glading A; Koziol JA; Krueger J; Ginsberg MH
Cancer Res; 2007 Feb; 67(4):1536-44. PubMed ID: 17308092
[TBL] [Abstract][Full Text] [Related]
58. Src mediates extracellular signal-regulated kinase 1/2 activation and autophagic cell death induced by cardiac glycosides in human non-small cell lung cancer cell lines.
Wang Y; Zhan Y; Xu R; Shao R; Jiang J; Wang Z
Mol Carcinog; 2015 Jun; 54 Suppl 1():E26-34. PubMed ID: 24610665
[TBL] [Abstract][Full Text] [Related]
59. Src kinase integrates PI3K/Akt and MAPK/ERK1/2 pathways in T3-induced Na-K-ATPase activity in adult rat alveolar cells.
Lei J; Ingbar DH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L765-71. PubMed ID: 21840963
[TBL] [Abstract][Full Text] [Related]
60. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
